Position in LIMN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$0
+$0 QoQ
Shares Held
13,976
-64.5% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LIMN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOLVERINE ASSET MANAGEMENT LLC holds $7,557,835 across 34 Biotechnology names. LIMN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GOSS |
Gossamer Bio, Inc.
|
12,894,746 | $2,127,633 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
22,340 | $1,771,338 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
10,909 | $1,447,951 | |
| 4 | TECH |
BIO-TECHNE Corp
|
10,471 | $739,776 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
2,330 | $561,460 | |
| 6 | NVAX |
Novavax Inc
|
37,037 | $348,888 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
14,925 | $318,947 | |
| 8 | IMCR |
Immunocore Holdings plc
|
2,822 | $89,598 |
All Filings in LIMN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 LIMNW | — | 13,976 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 LIMNW | — | 39,373 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 LIMNW | — | 62,795 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 LIMNW | — | 62,863 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 LIMNW | — | 102,987 | Shares | Defined | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||